RP
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
12.655
Exchange
XNAS - Nasdaq
1.014
Last period Debt / Equity ratio ,USD
What is Debt / Equity ratio ?
Debt / Equity ratio is the volume of debt obligations to the equity of the company. The value of 0.5 is the benchmark for Eyestock Rating calculation.
See also Royalty Pharma
Company Analysis
RPRX valuation, rating, competitors, insights and company profile
Eyestock Rating
RPRX financial analysis by Eyestock methodology
Valuation
RPRX valuation using historical relative method
Statements
RPRX Income Statements, Balance Sheet and Cash Flow Statements
Dividends
RPRX dividend yield and annual dividend
Debt / Equity ratio is the volume of debt obligations to the equity of the company. The value of 0.5 is the benchmark for Eyestock Rating calculation.
Royalty Pharma`s Debt / Equity ratio for the last twelve months ended 2024-06-30 is 1.014
